Patent directory · USPTO A61K / A61P
Patents matching “recombinant”
322 pharma patents match "recombinant" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 322 pharmaceutical patents matching "recombinant" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8426188
Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof
granted -
US 8394387
Recombinant modified Bacillus anthracis protective antigen for use in vaccines
granted -
US 8383132
Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
granted -
US 8367074
Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
granted -
US 8361733
Methods of identifying modulators of a cold-and-menthol-sensitive receptor (CMR1) and recombinant cells for use thereof
granted -
US 8323634
Stable formulations of highly concentrated recombinant human albumin-human granulocyte colony stimulating factor
granted -
US 8287879
Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
granted -
US 8287876
Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
granted -
US 8211447
Recombinant P. falciparum merozoite protein-142 vaccine
granted -
US 8163548
Recombinant bicistronic flaviviruses and methods of use thereof
granted -
US 8163294
Growth regulatable recombinant BCG compositions
granted -
US 8142787
Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
granted -
US 8124068
Recombinant intracellular pathogen immunogenic compositions and methods of use
granted -
US 8119769
Complement depletion using recombinant human C-3 derivatives
granted -
US 8101739
Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector
granted -
US 8039003
Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
granted -
US 8029804
Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
granted -
US 8012699
Recombinant antigens for diagnosis and prevention of murine typhus
granted -
US 8012490
Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
granted -
US 7960535
Recombinant lipidated PsaA protein, methods of preparation and use
granted -
US 7928194
Recombinant antigen for diagnosis and prevention of murine typhus
granted -
US 7923535
Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins
granted -
US 7919301
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
granted -
US 7871814
Recombinant bicistronic flaviviruses and methods of use thereof
granted